Effective Iron Supplement – Encicarb contains Ferric Carboxymaltose, used for the treatment of iron deficiency anemia (IDA) when oral iron is ineffective or not tolerated.

Rapid Iron Replenishment – Provides a high dose of iron in a single infusion, quickly restoring depleted iron stores.

Convenient Dosing – Allows administration of up to 1000 mg in one sitting, reducing the need for multiple hospital visits.

Improves Quality of Life – Helps reduce symptoms like fatigue, weakness, and shortness of breath caused by anemia.

Rapid Iron Replenishment – Encicarb 500 contains Ferric Carboxymaltose, an intravenous iron therapy for treating iron deficiency anemia when oral iron supplements are insufficient or poorly tolerated.

High-Dose Convenience – Provides up to 500 mg of iron per infusion, reducing the number of hospital visits and accelerating correction of iron deficiency.

Enhances Energy & Well-Being – Helps alleviate anemia-related symptoms such as fatigue, weakness, and shortness of breath.

Safe & Well-Tolerated – Designed to minimize gastrointestinal side effects commonly associated with oral iron.

Anticoagulant Therapy – Cutenox 60 contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) used to prevent and treat blood clots.

Prevents Deep Vein Thrombosis (DVT) & Pulmonary Embolism (PE) – Commonly prescribed after surgeries, in bedridden patients, or in those at high risk of clot formation.

Supports Heart Health – Used in the management of acute coronary syndromes (ACS), including unstable angina and heart attacks.

Reliable & Effective – Provides predictable anticoagulant activity with reduced need for frequent monitoring compared to unfractionated heparin.

Cancer Therapy – Cizumab 400 contains Bevacizumab, a monoclonal antibody used in the treatment of various cancers including colorectal cancer, lung cancer, kidney cancer, and ovarian cancer.

Inhibits Tumor Growth – Works by blocking vascular endothelial growth factor (VEGF), thereby preventing the formation of new blood vessels that supply tumors.

Improves Survival Outcomes – Enhances the effectiveness of chemotherapy, helping slow disease progression and extend patient survival.

Versatile Use – Administered in combination with other anti-cancer medicines for stronger therapeutic benefits.

Effective Anticoagulant – Cutenox contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) that prevents and treats harmful blood clots.

DVT & PE Prevention – Helps lower the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), especially after orthopedic or abdominal surgeries, or in bedridden patients.

Cardiac Care Support – Widely used in managing acute coronary syndromes (ACS), such as unstable angina and certain types of myocardial infarction.

Predictable & Safer Profile – Provides consistent anticoagulant effects with reduced need for frequent lab monitoring compared to conventional heparin.

Bone Strengthening Therapy – Denosurel 120 contains Denosumab, a monoclonal antibody that helps strengthen bones by reducing bone breakdown.

Treats Osteoporosis & Bone Loss – Prescribed for postmenopausal women, men at risk of fractures, and patients with bone loss due to cancer treatments.

Prevents Skeletal Complications – Used in cancer patients with bone metastasis to lower the risk of fractures, spinal cord compression, and need for radiation or surgery.

120 mg Pre-Filled Injection – Provides accurate dosing, administered subcutaneously by a healthcare professional once every 4 weeks (for cancer-related conditions) or as advised.

Effective Anticoagulant – Clexane 40 contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) that helps prevent and treat blood clots.

Prevents Deep Vein Thrombosis (DVT) – Commonly prescribed after surgeries (like orthopedic or abdominal surgery) and in bedridden patients to reduce clotting risks.

Manages Pulmonary Embolism & ACS – Also used in the treatment of pulmonary embolism (PE) and acute coronary syndrome (ACS) to improve cardiovascular outcomes.

Pre-Filled Syringe for Safety – Provides accurate 40 mg dose with ease of administration via subcutaneous injection

Therapeutic Use – Ambilon 50 contains Amphotericin B (Liposome formulation), an antifungal medicine used to treat severe systemic fungal infections and certain types of leishmaniasis.

Enhanced Safety Profile – Liposomal formulation reduces kidney toxicity and infusion-related side effects compared to conventional Amphotericin B.

Broad-Spectrum Antifungal Action – Effective against serious fungal infections such as aspergillosis, candidiasis, and cryptococcosis.

Targeted Delivery – Liposomes help deliver the drug directly to infected tissues, improving efficacy and tolerability.

Anemia Management in CKD – Darberel contains Darbepoetin Alfa, a long-acting erythropoiesis-stimulating agent (ESA) used to treat anemia associated with chronic kidney disease (CKD) in both dialysis and non-dialysis patients.

Stimulates Red Blood Cell Formation – Works by activating bone marrow to produce more red blood cells, improving hemoglobin levels and reducing anemia-related fatigue.

Extended Dosing Interval – Due to its prolonged half-life, Darberel requires less frequent dosing compared to conventional erythropoietin, offering convenience for patients.

Improves Patient Well-being – Helps reduce symptoms such as weakness, shortness of breath, and low energy, thereby enhancing quality of life.

Treats Anemia – Darbelife 40 contains Darbepoetin Alfa, a long-acting erythropoiesis-stimulating agent (ESA) used to treat anemia caused by chronic kidney disease (CKD) or chemotherapy.

Boosts Red Blood Cell Production – Stimulates bone marrow to increase red blood cell count, reducing fatigue and weakness related to low hemoglobin.

Long-Lasting Effect – Provides prolonged action compared to conventional erythropoietin, allowing less frequent dosing.

Improves Quality of Life – Helps patients regain strength, energy, and better oxygen circulation in the body.

Stimulates Red Blood Cell Production – Promotes bone marrow activity to increase red blood cell (RBC) count, improving oxygen transport and reducing fatigue.

Long-Lasting Effect – Compared to conventional erythropoietin, Cresp 40 has a prolonged half-life, allowing less frequent dosing.

Enhances Patient Well-Being – Helps relieve anemia-related symptoms such as weakness, tiredness, and shortness of breath.

Treats Anemia in CKD – Dargen 40 contains Darbepoetin Alfa 40 mcg, a long-acting erythropoiesis-stimulating agent (ESA) used to treat anemia associated with chronic kidney disease (CKD), including patients on dialysis.

Boosts Red Blood Cell Production – Stimulates the bone marrow to increase red blood cell (RBC) count, helping improve oxygen supply throughout the body.

Longer Duration of Action – Compared to conventional erythropoietin, darbepoetin has a longer half-life, allowing for less frequent dosing.

Improves Quality of Life – Reduces symptoms of anemia such as fatigue, weakness, and shortness of breath.

Stimulates Red Blood Cell Production – Works by stimulating the bone marrow to produce more red blood cells, reducing the need for frequent blood transfusions.

Long-Acting Formula – Has a longer half-life compared to conventional erythropoietin, allowing for less frequent dosing and improved patient convenience.

Improves Quality of Life – Helps relieve anemia-related symptoms such as fatigue, weakness, and shortness of breath.

Effective Anemia Treatment – Dargen 40 contains Darbepoetin Alfa 40 mcg, designed to treat anemia associated with chronic kidney disease (CKD) in both dialysis and non-dialysis patients.

Stimulates Red Blood Cell Production – Promotes bone marrow activity to increase red blood cell (RBC) count, improving oxygen delivery in the body.

Long-Acting Formula – Offers a prolonged half-life compared to conventional erythropoietin, allowing for less frequent dosing and improved patient convenience.

Improves Quality of Life – Relieves anemia-related symptoms such as weakness, tiredness, and shortness of breath, supporting better daily functioning.

Broad-Spectrum Antibiotic – Elores combines Ceftriaxone, a third-generation cephalosporin, with Sulbactam, a β-lactamase inhibitor, to effectively treat a wide range of bacterial infections.

Enhanced Efficacy – Sulbactam protects ceftriaxone from degradation by β-lactamase-producing bacteria, improving activity against resistant strains.

Treats Serious Infections – Indicated for respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and septicemia.

Rapid & Reliable Action – Administered intravenously or intramuscularly, providing fast therapeutic effects in hospitalized patients.

Anemia Management – Epofit 10000 IU contains Erythropoietin Alfa, used to treat anemia associated with chronic kidney disease (CKD), chemotherapy, or other medical conditions.

Stimulates Red Blood Cell Production – Activates the bone marrow to produce healthy red blood cells, improving oxygen delivery throughout the body.

High-Potency Dose – The 10,000 IU strength is suitable for patients requiring a higher dose to effectively manage severe anemia.

Improves Energy & Well-Being – Helps reduce fatigue, weakness, and shortness of breath related to low hemoglobin levels.

Broad-Spectrum Antibiotic – Eczas contains Ertapenem, a carbapenem-class antibiotic effective against a wide range of Gram-positive and Gram-negative bacteria.

Treats Severe Infections – Used in the management of complicated intra-abdominal infections, skin and soft tissue infections, urinary tract infections, community-acquired pneumonia, and acute pelvic infections.

Hospital & Clinical Use – Commonly prescribed for patients with moderate to severe bacterial infections that are resistant to other antibiotics.

Intravenous Administration – Provides fast action by delivering the drug directly into the bloodstream for effective treatment.

Therapeutic Use – Anfoe 6000 IU contains Erythropoietin Alfa, used in the treatment of anemia caused by chronic kidney disease (CKD), chemotherapy, or HIV therapy.

Stimulates Red Blood Cell Production – Activates the bone marrow to produce more red blood cells, helping restore normal hemoglobin levels.

Symptom Relief – Improves energy levels, reduces fatigue, and enhances overall quality of life in anemic patients.

High-Potency Dose (6000 IU) – Suitable for patients requiring moderate to higher doses, ensuring effective management of anemia.

Trusted Anticoagulant – Clexane contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) widely used for preventing and treating blood clots.

DVT & PE Prevention – Helps reduce the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), especially after surgeries or prolonged immobilization.

Cardiac Care Support – Effective in the management of acute coronary syndromes (ACS), including unstable angina and certain types of heart attacks.

Predictable Action – Offers reliable anticoagulant activity with less need for frequent laboratory monitoring compared to traditional heparin.

Chemotherapy Agent – Carbotero 450 contains Carboplatin, a platinum-based chemotherapy drug used in the treatment of various cancers, including ovarian, lung, head & neck, and testicular cancers.

Inhibits Cancer Cell Growth – Works by interfering with DNA replication in cancer cells, slowing or stopping tumor growth.

Combination Therapy – Often used alongside other chemotherapy drugs for enhanced effectiveness.

Intravenous Administration – Given in a hospital or clinical setting for precise dosing and safe administration.

Manages Anemia – Erypeg 50 is used to treat anemia associated with chronic kidney disease (CKD) and chemotherapy by stimulating red blood cell production.

Pegylated Long-Acting Formula – Contains Pegylated Recombinant Human Erythropoietin, which provides a prolonged effect, reducing the frequency of injections compared to conventional erythropoietin.

Boosts Red Blood Cell Count – Improves hemoglobin levels, oxygen transport, and reduces symptoms like fatigue, weakness, and breathlessness.

High-Dose 50 mcg Strength – Ensures effective treatment in patients requiring stronger erythropoietin therapy.

Therapeutic Use – Anfoe 10000 IU contains Erythropoietin Alfa, a medicine used to treat anemia caused by chronic kidney disease (CKD), chemotherapy, or HIV therapy.

High-Potency Dose (10000 IU) – Designed for patients who require stronger dosing to effectively manage anemia and restore hemoglobin levels.

Stimulates Red Blood Cell Production – Activates the bone marrow to produce healthy red blood cells, improving oxygen supply throughout the body.

Improves Energy & Well-Being – Helps reduce fatigue, weakness, and breathlessness associated with anemia.

Chemotherapy Agent – Cytogem 1000 contains Gemcitabine, an antimetabolite used to treat various cancers including pancreatic, lung, bladder, and breast cancers.

Inhibits Cancer Cell Growth – Interferes with DNA synthesis, preventing cancer cells from multiplying and promoting apoptosis (cell death).

Combination Therapy – Often used with other chemotherapy agents to enhance treatment effectiveness and improve outcomes.

Hospital-Based Administration – Administered via intravenous infusion under strict medical supervision for safe and precise dosing.

Advanced Prostate Cancer Therapy – Deghor 80 contains Degarelix, a GnRH antagonist used for the treatment of advanced prostate cancer.

Rapid Testosterone Suppression – Lowers testosterone levels quickly without the initial surge seen with GnRH agonists, helping reduce tumor-related symptoms.

Monthly Subcutaneous Injection – Designed for convenient monthly dosing under medical supervision.

Symptom & Disease Management – Helps control prostate cancer progression, reduce urinary symptoms, and manage bone pain in metastatic cases.

Effective chemotherapy drug for various types of cancers.

Provides reliable intravenous treatment under medical supervision.

Trusted hospital-grade formulation for oncology care.

Powerful Antifungal Therapy – Casfung 70 contains Caspofungin Acetate, an echinocandin-class antifungal used to treat serious fungal infections.

Effective Against Resistant Fungi – Indicated for invasive candidiasis, esophageal candidiasis, and invasive aspergillosis in patients unresponsive to other antifungal treatments.

Hospital-Based Administration – Given as an intravenous infusion under strict medical supervision to manage severe or life-threatening infections.

Rapid Action – Works by inhibiting fungal cell wall synthesis, leading to the destruction of pathogenic fungi.

Therapeutic Use – Cetrotide 0.25 contains Cetrorelix Acetate, a gonadotropin-releasing hormone (GnRH) antagonist used in assisted reproductive technology (ART) treatments.

Prevents Premature Ovulation – Helps control the release of luteinizing hormone (LH), preventing premature ovulation during controlled ovarian stimulation.

Supports Fertility Treatments – Commonly used in IVF (In Vitro Fertilization) procedures to improve the chances of successful egg retrieval.

Convenient Dosage – 0.25 mg pre-filled syringe or vial for subcutaneous injection, administered under medical supervision.

Therapeutic Use – Epofit contains Erythropoietin Alfa, a synthetic form of human erythropoietin used to treat anemia associated with chronic kidney disease (CKD), chemotherapy, and certain HIV treatments.

Boosts Red Blood Cell Production – Stimulates the bone marrow to increase red blood cell count, improving oxygen delivery throughout the body.

Improves Quality of Life – Helps reduce fatigue, weakness, and other symptoms caused by low hemoglobin levels.

Convenient Dosage Forms – Available in pre-filled syringes for accurate subcutaneous or intravenous administration under medical supervision

Powerful Antibiotic – Coly Monas 3 contains Colistimethate Sodium, a polymyxin-class antibiotic used to combat severe infections caused by multidrug-resistant Gram-negative bacteria.

Critical Infection Management – Effective in treating bloodstream infections, pneumonia, urinary tract infections, and infections caused by Pseudomonas, Acinetobacter, and Klebsiella species.

Hospital-Grade Therapy – Administered intravenously under strict medical supervision, making it suitable for severe or resistant infections.

Rapid Bacterial Action – Works by disrupting bacterial cell membranes, quickly eliminating dangerous pathogens.

Potent Antibiotic Therapy – Coly Monas 2 contains Colistimethate Sodium, a polymyxin-class antibiotic effective against multidrug-resistant Gram-negative bacterial infections.

Critical Infection Management – Used for severe infections such as pneumonia, bloodstream infections, urinary tract infections, and infections caused by Pseudomonas, Acinetobacter, and Klebsiella species.

Hospital-Grade Administration – Given intravenously under strict medical supervision, suitable for critically ill patients.

Rapid Bactericidal Action – Disrupts bacterial cell membranes, quickly eliminating harmful pathogens.

Targeted Cancer Therapy – Borviz 2.5 contains Bortezomib, a proteasome inhibitor used in the treatment of multiple myeloma and mantle cell lymphoma.

Inhibits Cancer Cell Growth – Blocks proteasome activity, leading to apoptosis (programmed cell death) in malignant plasma cells.

Combination Therapy – Often used with other chemotherapy agents or corticosteroids to enhance treatment efficacy.

Improves Disease Management – Helps reduce tumor burden, manage symptoms, and improve patient outcomes.